Novel PIK3CD mutations affecting N-terminal residues of p110δ cause activated PI3Kδ syndrome (APDS) in humans
- 1 October 2017
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 140 (4) , 1152-1156.e10
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Somatic gain-of-function mutations in PIK3CA in patients with macrodactylyHuman Molecular Genetics, 2012
- Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α ( PIK3CA )Proceedings of the National Academy of Sciences, 2012
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromesNature Genetics, 2012
- PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputsOncogene, 2012
- Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110αStructure, 2011
- A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial CarcinomasClinical Cancer Research, 2011
- Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory MechanismMolecular Cell, 2011
- Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signalsBlood, 2010
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- Rare cancer-specific mutations in PIK3CA show gain of functionProceedings of the National Academy of Sciences, 2007